Article
Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
Neutral
0.0
−100 Bearish
0
+100 Bullish
To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
CNBC Top Stories
Published
Apr 27, 2026 · 2:29 am
Article ID
bny7e56
Original URL
Open source
Sentiment Signal
Neutral
0.0
−100Neutral+100
More Like This